Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 13;49(1):zsaf212.
doi: 10.1093/sleep/zsaf212.

Genome-wide gene by sleepiness interaction analysis for sleep apnea

Collaborators, Affiliations

Genome-wide gene by sleepiness interaction analysis for sleep apnea

Pavithra Nagarajan et al. Sleep. .

Abstract

Study objectives: Excessive daytime sleepiness (EDS), influenced by environmental and social-behavioral factors, is reported by a subset of patients with sleep apnea-a group that may be at elevated cardiovascular risk. However, it is unclear whether sleep apnea with and without EDS have distinct genetic underpinnings. In this study, we perform gene-by-EDS interaction analyses for apnea hypopnea index, a diagnostic marker of sleep apnea severity, to understand EDS's influence on its underlying genetic risk.

Methods: Discovery interaction analyses for common variants and gene-based rare variants were conducted respectively using multi-ethnic Trans-Omics for Precision Medicine (N = 11 619) data, followed by replication and subsequent meta-analysis in additional Trans-Omics for Precision Medicine-imputed data (N = 8904). The 1 degree-of-freedom (1df) G × E test and the 2df joint G,G × E tests were utilized. Sex-stratified analyses were additionally performed.

Results: Discovery analysis revealed two common intronic variants-rs13118183 (CCDC3) and rs281851 (MARCHF1)-and three rare variant gene sets mapped to SCUBE2, TMEM26, and CPS4FL-to exhibit interaction with EDS. Meta-analysis revealed EDS interaction with 11 rare variant gene sets mapped to UBLCP1, MED31, RAP1GAP, CPNE5, MYMX, YY1, ZNF773, YBEY, IQCB1, PI4K2B, and CORO1A.

Conclusion: Genetic loci reveal connections to cardiovascular risk, insulin resistance, thiamine deficiency, and resveratrol mechanism. Discovered genetic signals may offer insight into pertinent biological pathways for sleep apnea patients with an excessively sleepy subtype. Statement of Significance Sleep apnea is a complex sleep disorder. Exemplifying this is the disparately varying estimates of presence of excessive daytime sleepiness (EDS) in patients, and persistent EDS that lingers despite treatment. Some data indicate that the excessively sleepy subtype of sleep apnea carries heightened cardiovascular risk. Whether EDS influences genetic risk factors underlying sleep apnea has not yet been investigated. This study addresses this gap, as the first genome-wide gene × EDS interaction study for apnea hypopnea index, the standard sleep apnea severity metric. Genetic loci that have been previously unconsidered for sleep apnea are revealed. Discovered interaction signals highlight pathways in metabolism, genes associated with cardiometabolic traits, and therapeutic agents influencing obesity, blood pressure, oxidative stress, and apnea hypopnea index.

Keywords: apnea hypopnea index; excessive daytime sleepiness; gene–environment interaction; sleep apnea.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
Overall conceptual workflow of this study.
Figure 2
Figure 2
Common variant × EDS interaction effect on AHI. (a) Manhattan plot of 1df G×E interaction effect displays two common genetic variants significant at the genome-wide level (p < 5e-08)—rs13118183 (MARCHF1) and rs281851 (CCDC3)—for their interaction effect with EDS. (b) Forest plot of rs13118183 (MARCHF1) association with AHI in EDS and non-EDS groups, stratified by sex. (c) Forest plot of rs281851 (CCDC3) association with AHI in EDS and non-EDS groups, stratified by sex.

References

    1. Redline S, Azarbarzin A, Peker Y. Obstructive sleep apnoea heterogeneity and cardiovascular disease. Nat Rev Cardiol. 2023;20(8):560–573. 10.1038/s41569-023-00846-6 - DOI - PubMed
    1. Szily M, Tarnoki AD, Tarnoki DL, et al. Genetic influences on the onset of obstructive sleep apnoea and daytime sleepiness: a twin study. Respir Res. 2019;20(1):125. 10.1186/s12931-019-1095-x - DOI - PMC - PubMed
    1. Sofer T, Kurniansyah N, Murray M, et al. Genome-wide association study of obstructive sleep apnoea in the Million Veteran Program uncovers genetic heterogeneity by sex. EBioMedicine. 2023;90:104536. 10.1016/j.ebiom.2023.104536 - DOI - PMC - PubMed
    1. Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med. 2021;133(7):772–783. 10.1080/00325481.2021.1948305 - DOI - PubMed
    1. Huang T, Goodman M, Li X, et al. C-reactive protein and risk of OSA in four US cohorts. Chest. 2021;159(6):2439–2448. 10.1016/j.chest.2021.01.060 - DOI - PMC - PubMed

Substances

Grants and funding